One-carbon is receiving a seed investment

by admin
september 10, 2021

One-carbon is receiving a seed investment from its founders to strengthen the financial situation and secure continuous pre-clinical development of MTHFD2 inhibitors.

Rekommenderade artiklar

One-carbon Therapeutics AB announces the addition of multiple international experts to its Scientific Advisory Board

Professor Johann de Bono, Head of the Division of Clinical

We will be in Copenhagen for the NLS days 29-30 November

We look forward to meeting you there!

Trick or trap by One Carbon Therapeutics

Read a short story of One-carbon Therapeutics achievements so far

Menu bar